Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: Myeloma response assessment and diagnosis system (MY-RADS)

Christina Messiou, Jens Hillengass, Stefan Delorme, Frédéric E. Lecouvet, Lia A. Moulopoulos, David J. Collins, Matthew D. Blackledge, Niels Abildgaard, Brian Østergaard, Heinz Peter Schlemmer, Ola Landgren, Jon Thor Asmussen, Martin F. Kaiser, Anwar Padhani

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Abstract

Acknowledging the increasingly important role of whole-body MRI for directing patient care in myeloma, a multidisciplinary, international, and expert panel of radiologists, medical physicists, and hematologists with specific expertise in whole-body MRI in myeloma convened to discuss the technical performance standards, merits, and limitations of currently available imaging methods. Following guidance from the International Myeloma Working Group and the National Institute for Clinical Excellence in the United Kingdom, the Myeloma Response Assessment and Diagnosis System (or MY-RADS) imaging recommendations are designed to promote standardization and diminish variations in the acquisition, interpretation, and reporting of whole-body MRI in myeloma and allow response assessment. This consensus proposes a core clinical protocol for whole-body MRI and an extended protocol for advanced assessments.

Original languageEnglish (US)
Pages (from-to)5-13
Number of pages9
JournalRadiology
Volume291
Issue number1
DOIs
StatePublished - Apr 2019
Externally publishedYes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: Myeloma response assessment and diagnosis system (MY-RADS)'. Together they form a unique fingerprint.

Cite this